Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Sex-related disparities in out...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials

Bibliographic Details
Main Authors: Matthew Ledenko, Samuel O. Antwi, Shiho Arima, Julia Driscoll, Junji Furuse, Heinz-Josef Klümpen, Finn Ole Larsen, David K. Lau, Annett Maderer, Alice Markussen, Markus Moehler, Lynn E. Nooijen, Walid L. Shaib, Niall C. Tebbutt, Thierry André, Makoto Ueno, Rachel Woodford, Changhoon Yoo, Mark M. Zalupski, Tushar Patel
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
Biliary cancers
chemotherapy
gemcitabine
therapeutic response
survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.963753/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.963753/full

Similar Items

  • Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases
    by: Alexander Desuki, et al.
    Published: (2019-01-01)
  • Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patients
    by: Anna Haupts, et al.
    Published: (2021-08-01)
  • Collagen turnover biomarkers to predict outcome of patients with biliary cancer
    by: Leonard Kaps, et al.
    Published: (2025-02-01)
  • Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program
    by: Markus Moehler, et al.
    Published: (2019-01-01)
  • Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis?
    by: Assaf Moore, et al.
    Published: (2020-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs